FOXP3 and metabolic dysfunction-associated steatotic liver disease: At baseline, NAFLD-HCC subjects had a higher percentage of regulatory T cells (Tregs; CD3+CD4+CD25+Foxp3+) compared to NAFLD-cirrhosis and non-NAFLD controls (P < 0.0001) (Fig. 1).